XML 47 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

Shareholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Stockholders' Equity Note [Abstract] |
Schedule of Compensation Costs Charged Against Income for the 2011 Share Incentive Plan | The compensation costs charged against income for the 2011 Share Incentive Plan were comprised as follows:
|  | Years Ended December 31, |
|  | 2 0 2 4 |  |  | 2 0 2 3 |  |  | 2 0 2 2 |
|  | U.S. dollars in thousands |
Cost of revenues |  | $ | 52 |  |  | $ | 60 |  |  | $ | 63 |
Research and development expenses |  |  | 163 |  |  |  | 180 |  |  |  | 159 |
Selling and marketing expenses |  |  | 3 |  |  |  | 3 |  |  |  | 1 |
General and administrative expenses |  |  | 34 |  |  |  | 38 |  |  |  | 35 |
|  | $ | 252 |  |  | $ | 281 |  |  | $ | 258 |
Schedule of Status of the 2011 Share Incentive Plan | The following is a summary of the status of the 2011 Share Incentive Plan as of December 31, 2024, 2023 and 2022, and changes during the years ended on those dates:
|  | Years Ended December 31, |
|  | 2 0 2 4 |  |  | 2 0 2 3 |  |  | 2 0 2 2 |
|  | Number |  |  | Weighted average exercise price |  |  | Number |  |  | Weighted average exercise price |  |  | Number |  |  | Weighted average exercise price |
Options outstanding at the beginning of year |  |  | 501,000 |  |  | $ | 0.003 |  |  |  | 452,500 |  |  | $ | 0.003 |  |  |  | 269,500 |  |  | $ | 0.003 |
Changes during year: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Granted (a) |  |  | 200,000 |  |  | $ | 1.972 |  |  |  | 132,000 |  |  | $ | 0.003 |  |  |  | 304,000 |  |  | $ | 0.003 |
Exercised |  |  | (181,500 | ) |  | $ | 0.003 |  |  |  | (60,500 | ) |  | $ | 0.003 |  |  |  | (67,000 | ) |  | $ | 0.003 |
Forfeited |  |  | (26,000 | ) |  | $ | 0.003 |  |  |  | (15,000 | ) |  | $ | 0.003 |  |  |  | (54,000 | ) |  | $ | 0.003 |
Expired |  |  | (4,000 | ) |  | $ | 0.003 |  |  |  | (8,000 | ) |  | $ | 0.003 |  |  |  | - |  |  | $ | 0.003 |
Options outstanding at the end of year |  |  | 489,500 |  |  | $ | 0.807 |  |  |  | 501,000 |  |  | $ | 0.003 |  |  |  | 452,500 |  |  | $ | 0.003 |
Options exercisable at the end of year |  |  | 21,000 |  |  | $ | 0.003 |  |  |  | 30,000 |  |  | $ | 0.003 |  |  |  | 25,500 |  |  | $ | 0.003 |
Weighted average grant date fair value of options granted during the year (b) |  |  |  |  |  | $ | 0.09 |  |  |  |  |  |  | $ | 1.28 |  |  |  |  |  |  | $ | 1.58 |
(a) | In the year ended December 31, 2024, the options were granted to the Company’s Chief Executive Officer with an exercise price equal to the average closing price per share of the Company’s ordinary shares on the Nasdaq Stock Market during the 30 trading day period immediately preceding the date of grant of such option. In the years ended December 31, 2023 and 2022, the options were granted with an exercise price equal to par value of NIS 0.01 ($0.003).
(b) | The fair value of each stock option granted is computed on the date of grant according to the Black-Scholes option pricing model with the following assumptions:
Schedule of Stock Option Granted is Computed on the Date of Grant According to the Black-Scholes Option Pricing Model |
|  | Years Ended December 31, |
|  | 2 0 2 4 |  |  | 2 0 2 3 |  |  | 2 0 2 2 |
Dividend yield |  |  | 12.31 | % |  |  | 10.48 | % |  |  | 9.69 | %
Expected volatility* |  |  | 25.79 | % |  |  | 51 | % |  |  | 30 | %
Average risk-free interest rate |  |  | 4.14 | % |  |  | 4.53 | % |  |  | 1.99 | %
Expected average term - in years |  |  | 3.88 |  |  |  | 3.88 |  |  |  | 3.88 |
| * | Volatility is based on the historical volatility of the Company’s share price for periods matching the expected term of the option until exercise.
Schedule of Information about Options Outstanding and Exercisable | The following table summarizes information about outstanding options and exercisable options as of December 31, 2024:
|  |  | Options Outstanding |  |  | Options Exercisable |
|  |  | Number |  |  | Weighted |  |  |  |  |  | Number |  |  | Weighted |  |  |  |
|  |  | outstanding |  |  | average |  |  | Weighted |  |  | exercisable |  |  | average |  |  | Weighted |
Range of |  |  | at |  |  | remaining |  |  | average |  |  | at |  |  | remaining |  |  | average |
exercise |  |  | December 31, |  |  | contractual |  |  | exercise |  |  | December 31, |  |  | contractual |  |  | exercise |
prices |  |  | 2 0 2 4 |  |  | life |  |  | price |  |  | 2 0 2 4 |  |  | life |  |  | price |
|  |  |  |  |  | Years |  |  |  |  |  |  |  |  | Years |  |  |  |
$ | 0.003 - 1.972 |  |  |  | 489,500 |  |  |  | 3.5 |  |  | $ | 0.807 |  |  |  | 21,000 |  |  |  | 1.29 |  |  | $ | 0.003 |

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration